CYP2C9 Activity Evaluated With a Simple Finger Prick

NCT01026714 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: flurbiprofen
DRUG: flurbiprofen, rifampicin
DRUG: flurbiprofen + fluconazole

Sponsor

University Hospital, Geneva